Assembly Biosciences ASMB
NASDAQ ASMB
$22.54 -0.44 (-1.91%)
At close: Oct 2, 2026 · 4:00 PM EDT

Assembly Biosciences (ASMB) Cash & Current Investments (2010 - 2026)

Updated

Assembly Biosciences' Cash & Current Investments came in at $320.36 million for Q2 2026, up 327.3% from $74.98 million a year earlier and up 41.4% from the prior quarter.

Analysis

Assembly Biosciences (ASMB) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Assembly Biosciences' Cash & Current Investments was $248.11 million, up 121.4% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 2.8% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $112.08 million in FY2024 (-13.9%), $130.25 million in FY2023 (+42.2%), $91.61 million in FY2022 (-37.5%) and $146.63 million in FY2021 (-32.2%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments in data going back to Q3 2010.
  • Year-over-year, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 97.9% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 327.3%), and the weakest in Q3 2023 (a decline of 57.5%).
  • Business Quant data shows ASMB's Cash & Current Investments at $226.6 million (Q1 2026), $248.11 million (Q4 2025) and $232.56 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Assembly Biosciences 447.43 Mn -580.20 Mn - 320.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 320.36 Mn
Mar 31, 2026 226.60 Mn
Dec 31, 2025 248.11 Mn
Sep 30, 2025 232.56 Mn
Jun 30, 2025 74.98 Mn
Mar 31, 2025 91.03 Mn
Dec 31, 2024 112.08 Mn
Sep 30, 2024 94.95 Mn
Jun 30, 2024 109.22 Mn
Mar 31, 2024 112.98 Mn
Dec 31, 2023 130.25 Mn
Sep 30, 2023 46.21 Mn
Jun 30, 2023 59.83 Mn
Mar 31, 2023 73.02 Mn
Dec 31, 2022 91.61 Mn
Sep 30, 2022 108.65 Mn
Jun 30, 2022 116.69 Mn
Mar 31, 2022 123.00 Mn
Dec 31, 2021 146.63 Mn
Sep 30, 2021 180.90 Mn
API Access

Assembly Biosciences Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ASMB&period=max&api_key=YOUR_API_KEY